Clovibactin-Get quote

Description

Clovibactin is an antibiotic for drug-resistant bacterial pathogens without detectable resistance. Clovibactin TFA inihibits cell wall synthesis by targeting pyrophosphate of peptidoglycan precursors[1].—COVID-19-immunoregulation–C43H70N10O11—-[1]Shukla R, et al. A new antibiotic from an uncultured bacterium binds to an immutable target. Preprint. bioRxiv. 2023;2023.05.15.540765. Published 2023 May 15.–2247194-77-8–903.08—-N[C@@H](CC1=CC=CC=C1)C(N[C@H](CC(C)C)C(N[C@H](CCCCN)C(N[C@@H](CO)C(N[C@@H]2[C@@H](OC([C@@H](NC([C@@H](NC([C@@H](NC2=O)C)=O)CC(C)C)=O)CC(C)C)=O)C(N)=O)=O)=O)=O)=O–Infection–10 mM in DMSO–Antibiotic;Bacterial—-Anti-infection–Peptides